Pfizer asks US officials to OK promising COVID-19 pill

Photo courtesy of Pfizer via AP

Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization.

Posted: Nov 16, 2021 2:03 PM

WASHINGTON (AP) — Pfizer is submitting its experimental pill for COVID-19 for U.S. authorization, setting the stage for a likely launch of the promising therapy in coming weeks.

The company’s antiviral is one of a handful of pills that have recently been shown to significantly cut hospitalizations and deaths among people infected with COVID-19.

If authorized by the Food and Drug Administration it could be a major step toward managing the pandemic, allowing patients to treat themselves at home.

FDA regulators will scrutinize company data on the safety and effectiveness of the drug, which will be sold as Paxlovid, before making a decision.

Lafayette
Partly Cloudy
51° wxIcon
Hi: 59° Lo: 34°
Feels Like: 51°
New Iberia
Partly Cloudy
52° wxIcon
Hi: 56° Lo: 35°
Feels Like: 52°
Ville Platte
Cloudy
55° wxIcon
Hi: 56° Lo: 32°
Feels Like: 55°
Abbeville
Mostly Cloudy
52° wxIcon
Hi: 57° Lo: 38°
Feels Like: 52°
Crowley
Cloudy
50° wxIcon
Hi: 55° Lo: 35°
Feels Like: 50°
St. Martinville
Partly Cloudy
52° wxIcon
Hi: 55° Lo: 33°
Feels Like: 52°
Opelousas
Partly Cloudy
55° wxIcon
Hi: 57° Lo: 32°
Feels Like: 55°
Tracking rain and then cooler by midweek

Community Events